Skip to main content
Fig. 2 | Gut Pathogens

Fig. 2

From: Efficacy of tailored second-line therapy of Helicobacter pylori eradication in patients with clarithromycin-based treatment failure: a multicenter prospective study

Fig. 2

Antibiotic resistance rates a The metronidazole-, clarithromycin-, and levofloxacin-resistance rates in the total population. b Multidrug-resistant infections. None, Single, Dual, and Triple indicate no, single, dual, and triple resistance to clarithromycin, levofloxacin, and metronidazole in the TBQT group, respectively. Multidrug-resistant strains were predominant, with 64.8% of strains showing dual or triple resistance

Back to article page
\